Table 1 Baseline characteristics of the study participants
Variable | Nadroparin group (n = 152) | Enoxaparin group (n = 113) | Dalteparin group (n = 45) | P value |
|---|---|---|---|---|
Age (years, mean ± SD) | 32 ± 3.4 | 32 ± 3.5 | 31 ± 3.5 | 0.20 |
≤ 30 years (n, %) | 51 (33.6%) | 36 (31.9%) | 18 (40.0%) | 0.62 |
30–35 years (n, %) | 62 (40.7%) | 41 (36.2%) | 19 (42.2%) | 0.69 |
≥ 35 years (n, %) | 39 (25.7%) | 36 (31.9%) | 8 (17.8%) | 0.18 |
BMI (kg/m2, mean ± SD) | 22.2 ± 2.7 | 21.7 ± 2.7 | 21.8 ± 2.9 | 0.31 |
BMI > 24 kg/m2 (n, %) | 32 (21.1%) | 23 (20.4%) | 9 (20.0%) | 0.98 |
Previous miscarriages (median, IQR) | 2 (2–6) | 2 (2–6) | 3 (2–4) | 0.83 |
Previous live birth (n, %) | 10 (6.6%) | 9 (8.0%) | 3 (6.7%) | 0.90 |
Gestational age (days, mean ± SD) | 117 ± 37.7 | 122 ± 39.8 | 111 ± 29.9 | 0.23 |